Back to search

Article

Treating earlier, spending less: cost-effectiveness and budget impact of immediate versus delayed antiretroviral therapy for HIV in Japan

2026-08-26

Abstract excerpt

<h4>Background.</h4> In Japan, lifelong antiretroviral therapy (ART) is funded through the physical disability (immune dysfunction) certification pathway, which requires two laboratory assessments four weeks or more apart. This statutory pathway, rather than clinical need, contributes to a median diagnosis-to-ART interval of about 42 days. We evaluated relaxing or reforming it to permit immediate ART. <h4>Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d5f54fe-0665-5ad0-9a82-b7701bfae950
DOI
10.64898/2026.08.23.26361165
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treating earlier, spending less: cost-effectiveness and budget impact of immediate versus delayed antiretroviral therapy for HIV in JapanDOI 10.64898/2026.08.23.26361165
The shifting burden of mortality among men with HIV in Japan between 2007 and 2024: A single-center retrospective cohort studySemantic proximity
Association Between ART Initiation Timing and Treatment Outcomes in Older People Living With HIV: A Longitudinal Study from Baise, ChinaSemantic proximity
A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In VivoSemantic proximity
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035Semantic proximity
Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: a comparison of behavioral, acquisition-risk based, and economic metricsSemantic proximity
Cost-Effectiveness of Interventions to Improve HIV Pre-Exposure Prophylaxis Initiation, Adherence, and Persistence among Men Who Have Sex with MenSemantic proximity
Opportunities for cost reduction of current first-line WHO-recommended oral antiretroviral therapy: replacing tenofovir disoproxil fumarate with tenofovir alafenamideSemantic proximity
Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized unblinded trialSemantic proximity
Cost-effectiveness analysis of triple therapy with protease inhibitors in treatment-naive hepatitis C patients.Semantic proximity
Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationSemantic proximity
The Cost-effectiveness of One-step Point-of-care Hepatitis C Virus RNA Testing in the United StatesSemantic proximity
Cost–Benefit Analysis of a Mobile Community-Based Electronic Medical Record System for Community Differentiated HIV Service Delivery in Lilongwe, MalawiSemantic proximity
Select a neighboring publication to make it the new centre.